Stock Details
BDX is Becton, Dickinson and Company's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 242.35$. Average daily volumn in 3 months 1.12M. Market cap 70.09B



Stock symbol : BDX. Exchange : NYSE. Currency : USD
Lastest price : 245.17$. Total volume : 607.88k. Market state POST
Click reload if you want to check the lastest price on market!!!

Becton, Dickinson and Company (BDX)
Last Price
245.17$
Change
2.24
Volume
607.88k

Previous Close242.93
Open244.05
Day Range243.37-245.20
Bid0.00 x 800
Ask0.00 x 800
Volume607.88k
Average Volume1.12M
Market Cap70.09B
Beta0.56
52 Week Range215.90-277.29
Trailing P/E47.24
Foward P/E18.00
Dividend (Yield %)1.51%
Ex-Dividend Date2023-03-09



Financial Details


According to Becton, Dickinson and Company's financial reports the company's revenue in 2022 were 18.87B an decrease(-5.26%) over the years 2021 revenue that were of 19.13B. In 2022 the company's total earnings were 1.78B while total earnings in 2021 were 2.09B(-50%).


Loading ...



Organization

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors an... d extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Market Cap:
70.09B
Revenue:
18.87B
Total Assets:
52.93B
Total Cash:
1.01B


News about "Becton, Dickinson and Company"

Becton, Dickinson and Company (NYSE:BDX) Goes Ex-Dividend Soon

Source from : Yahoo Finance - 24 days ago

Readers hoping to buy Becton, Dickinson and Company (NYSE:BDX) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend date is usually ...See details»


Becton Dickinson and Co

Source from : Reuters - 2 years ago

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment ...See details»


Shareholders in Becton Dickinson (NYSE:BDX) are in the red if they invested a year ago

Source from : YAHOO!Finance - 1 days ago

It's easy to feel disappointed if you buy a stock that goes down. But sometimes a share price fall can have more to ...See details»


Becton Dickinson & Co. stock falls Tuesday, underperforms market

Source from : MarketWatch - 2 days ago

Shares of Becton Dickinson & Co. sank 0.39% to $241.23 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the ...See details»


Becton, Dickinson And Company

Source from : Statista - 2 month ago

Becton, Dickinson And Company was founded in 1897 and operates in United States. The company engages in the sector 'Medical or Dental Instruments & Supplies' (ISIC: 3250). The industry belongs to ...See details»


ROUNDUP: Becton, Dickinson And Co. Q3 Profit Down, But Beats Estimates; Ups 2022 Guidance Above View

Source from : Finanznachrichten - 4 days ago

Becton, Dickinson and Company (BDX) reported a profit for third quarter that decreased from last year but beat the Street estimates. The company's earnings came in at $338 million, or $1.18 per share.See details»


Becton, Dickinson And (NYSE: BDX)

Source from : The Motley Fool - 9 days ago

Get a list of current -- and potential future -- Dividend Kings and learn how to leverage these strong companies to build wealth.See details»


Becton Dickinson and Company (BDX) vs. Its Peers: A Comparison

Source from : newsheater - 7 days ago

Becton Dickinson and Company (NYSE: BDX) has a price-to-earnings ratio of 46.16x that is above its average ratio. Additionally, the 36-month beta value for BDX is 0.54. There are mixed opinions on the ...See details»


Becton Dickinson & Co. Dep. Pfd. (Rep. 1/20th Pfd. Series B)

Source from : Wall Street Journal - 13 days ago

Thomas E. Polen Chairman, President & Chief Executive Officer Advanced Medical Technology Association, Hackensack Meridian Health Foundation, Inc., The Center For Discovery & Innovation, Becton ...See details»


Client Profile: Becton, Dickinson & Co

Source from : OpenSecrets.org - 6 month ago

A special interest's lobbying activity may go up or down over time, depending on how much attention the federal government is giving their issues. Particularly active clients often retain multiple ...See details»


Becton, Dickinson and Company

Source from : Fortune - 1 month ago

© 2023 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...See details»


Becton Dickinson & Co.

Source from : Barron's - 1 year ago

Becton, Dickinson & Co. engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments ...See details»


Becton, Dickinson and Company Common Stock (BDX)

Source from : Nasdaq - 3 month ago

Market Cap (Capitalization) is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common ...See details»


BDX Becton, Dickinson and Company

Source from : Seeking Alpha - 7 days ago

**NM signifies a non meaningful value. A dash signifies the data is not available.See details»